Raltegravir opnåede virologisk respons (med Non- Completer=Failure analysen) for HIV RNA < 50 kopier/ ml hos 61, 7% af patienterne ved uge 16 og hos 62, 1% ved uge 48.
Raltegravir achieved virologic responses (using Not Completer=Failure approach) of HIV RNA < 50 copies/ ml in 61.7% of patients at Week 16 and in 62.1% at Week 48.